The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell therapy that may bypass lymphodepletion, paving the way for a phase 1 trial in lupus and other autoimmune diseases. The trial will involve the use of Allogene Therapeutics’ Dagger technology, which aims to reduce, or avoid entirely, the need for pre-treatment
Your Ranking for WORD DOC Jul 21, 2023 YOU HEALIO’S USER AVERAGE Wins Percentage This is your percentage of games you won. 0% 0% Current…
Having a child with vs. without cystic fibrosis heightened the odds for job lock and curtailed employment among parents/caregivers, according to a research letter published…
the risk of progression and the need for surgery, with an inversely proportional relationship to the number of hours worn. However, therapeutic adherence and its…
t pain, including pain severity, interference with daily activities, and medication use (these pain dimension questions were not administered in all countries). Our analytical sample…
pecial small fiber neurophysiology such as C-fiber microneurography. Microneurography in particular has shown increased spontaneous activity, mechanosensitivity, and enhanced activity-induced slowing in C fibers of…
using a random-effects model to generate pooled estimates for overall response, complete remission, partial response, and adverse events, with subgroup analyses by myositis type and…
Individuals with unhealthy lifestyles may derive the most benefit from aspirin for colorectal cancer prevention, according to results of a prospective cohort study.Regular aspirin use…
BOSTON — Patients who were taking lipid-lowering medications experienced more severe anaphylaxis after insect stings, according to an abstract presented at the American College of…
📢 EULAR proudly launches EULAR Rheumatology Open (ERO), a new open-access journal hosted by Elsevier, dedicated to advancing global rheumatology research. …
In recent years, orthopaedic surgeons have attempted to decrease opioid consumption through multimodal pain management. However, a limited effort has been made to eliminate opioids…
